Ligand Pharmaceuticals
LGND
LGND
305 hedge funds and large institutions have $2.85B invested in Ligand Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 140 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 140
36% less call options, than puts
Call options by funds: $53.4M | Put options by funds: $83.9M
41% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 49
Holders
305
Holding in Top 10
4
Calls
$53.4M
Puts
$83.9M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$18M | |
| 3 | +$17.1M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$13.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$25.2M | |
| 3 | -$17.4M | |
| 4 |
Renaissance Technologies
New York
|
-$15.4M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$13.1M |